Glucosulfone sodium

This classification denotes a sulfone anti-infective agent with the molecular formula C24H34N2O18S3.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6RLN7D44F, chemically known as sodium glucosulfone, injection but more generally known as glucosulfone, which bears US NIH Compound Identifier 3481. European Medicines Agency schedules Glucosulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07939MIG. The term GLUCOSULFONE is an International Non-Proprietary Name. GLUCOSULFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glucosulfone sodium under HS 29309085. As of Q4 2014, GLUCOSULFONE SODIUM remains the US FDA Preferred Term for this commodity. Glucosulfone sodium bears US NLM identifiers UMLS ID C0301338 and NCI Concept Code C87219. SMILES: C1CC(CCC1NC([C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)S(=O)(=O)[O-])S(=O)(=O)C2CCC(CC2)NC([C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)S(=O)(=O)[O-].[NA+].[NA+].